Erwin Cruz

Erwin Cruz
Erwin Cruz is member of the Olivares’ Life Science Law Group since 2008, assisting clients to add value to their businesses and projects in Mexico. He achieves this commitment, for example, not only by getting exclusive rights to clients, but also by developing and successfully implementing strategies to enforce exclusive rights and fair trade rules against potential infringers. Erwin provides high qualified regulatory assistance related to prod- ucts’ marketing, labelling and advertising. He has extensive expertise on Intellectual Property Rights and Regulatory compliance related to Pharma, Agro and Software industries. He constantly participates in international and national conferences, and meets …
Erwin Cruz is member of the Olivares’ Life Science Law Group since 2008, assisting clients to add value to their businesses and projects in Mexico. He achieves this commitment, for example, not only by getting exclusive rights to clients, but also by developing and successfully implementing strategies to enforce exclusive rights and fair trade rules against potential infringers. Erwin provides high qualified regulatory assistance related to prod- ucts’ marketing, labelling and advertising.

He has extensive expertise on Intellectual Property Rights and Regulatory compliance related to Pharma, Agro and Software industries. He constantly participates in international and national conferences, and meets key authorities in Mexico for these industries, such as the Patent and Trademark Office (IMPI), the Healthcare Products Regulatory Agency (COFEPRIS), the Plant Breeders’ Rights Office (SNICS) and Bureau of Consumer Protection (PROFECO).

Erwin has written several articles over litigation and regulations for pharmaceuticals, biotechnologies, agri- businesses, food and beverages.
See more

Articles: Erwin Cruz

Cannabis and Narcotics for Medicinal Use in Mexico

Mexico / Representatives of Olivares, one of the leading law firms in Mexico, explain the evolving status of cannabis and narcotics for medicinal use in the country. A new Bill authorizing the use of cannabis for medical treatments was passed by the Senate in December 2016, but there is still a long way to go before it,…

See more